Therapeutic efficacy potential of PXL770 - a novel direct AMPK-activator and PXL065 – deuterium-stabilized R-pioglitazone - for X-linked adrenoleukodystrophy
Jaspreet Singh, et al. – November 2020, ALD Connect Annual Meeting
Therapeutic efficacy potential of PXL770 - a novel direct AMPK-activator and PXL065 – deuterium-stabilized R-pioglitazone - for X-linked adrenoleukodystrophy
Jaspreet Singh, et al. – November 2020, ALD Connect Annual Meeting